AtonRa Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-90,308
Closed -$449K 120
2022
Q2
$449K Buy
90,308
+71,734
+386% +$376K 0.41% 106
2022
Q1
$132K Sell
18,574
-3,104
-14% -$25.7K 0.07% 112
2021
Q4
$394K Buy
21,678
+1,078
+5% +$23.3K 0.14% 113
2021
Q3
$403K Buy
20,600
+3,049
+17% +$116K 0.13% 113
2021
Q2
$786K Buy
+17,551
New +$814K 0.29% 107

Other funds holding CELL

AtonRa Partners's CELL Position: Q3 2022 in Review

AtonRa Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 90,308 shares — an estimated $449K sold.

AtonRa Partners first reported a position in CELL in Q2 2021 and held it in 5 quarters. The position peaked at $786K in Q2 2021. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.

  • AtonRa Partners reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • AtonRa Partners sold 90,308 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $449K.
  • AtonRa Partners first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • AtonRa Partners's PhenomeX Inc. Common Stock position peaked at $786K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.

Based on AtonRa Partners's 13F filing for Q3 2022, filed 14 Nov 2022.